Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
The molecular classification of endometroid ovarian carcinomas (EnOC) has not been established, preventing the development of stratified therapeutic approaches. Here the authors characterise the molecular landscape of EnOC by whole exome sequencing, identifying clinically distinct disease subtypes.
Guardado en:
Autores principales: | Robert L. Hollis, John P. Thomson, Barbara Stanley, Michael Churchman, Alison M. Meynert, Tzyvia Rye, Clare Bartos, Yasushi Iida, Ian Croy, Melanie Mackean, Fiona Nussey, Aikou Okamoto, Colin A. Semple, Charlie Gourley, C. Simon Herrington |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/232b42338ac04ca39f011da44d0890a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
por: Robert L. Hollis, et al.
Publicado: (2021) -
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
por: Robert L. Hollis, et al.
Publicado: (2021) -
Carcinoma endometrioide sincrónico de ovario y endometrio.
por: Laguna Olmos,Mariano, et al.
Publicado: (2020) -
Nicotinamide N‐methyltransferase is related to MELF pattern invasion in endometrioid carcinoma
por: Shinichiro Tahara, et al.
Publicado: (2021) -
Estimation of the polymorphism of matrix metal proteinase genes in patients with endometrioid ovarian cysts
por: Svetlana O. Dubrovina, et al.
Publicado: (2021)